Global Mouse Nerve Growth Factor for Injection Market Size, Share and Trends Analysis Report, By Type (30μg (15000U), 20μg (9000U)), By Application (Peripheral Neuropathies, Central Neurodegenerative Diseases, Autoimmune diseases, and Others ), Forecast Period (2022-2028)

The global mouse nerve growth factor for injection market is anticipated to grow at a CAGR of 4.2% during the forecast period (2022-2028). The mouse nerve growth factor was the first neurotrophic factor discovered, and it has the ability to keep central and peripheral neurons alive while also aiding their development, differentiation, and regeneration. Mouse nerve growth factor for injection has sparked a lot of interest as a potential Alzheimer’s disease therapeutic target. Alzheimer’s disease is characterized by cholinergic neuron failure in the basal forebrain. High-affinity and low-affinity (p75NTR) neurotrophin receptors are expressed within the basal forebrain cholinergic neurons, while mouse nerve growth factor is created and secreted by cells in the cortex and hippocampus.

Despite the availability of a number of nonpharmacologic and pharmacologic therapeutic methods, chronic pain remains a huge global burden. As a result, new analgesics with novel mechanisms of action are required. Antibodies directed against mouse nerve growth factors (NGF-Abs) are a new class of medicines in development for the treatment of chronic pain diseases like osteoarthritis and chronic low-back pain in this regard. The evidence for NGF’s pronociceptive actions, which include contributing to peripheral and central sensitization via tropomyosin receptor kinase, is summarised in this narrative overview. Local neuronal sprouting is activated and stimulated. The involvement of NGF in osteoarthritis and chronic low-back pain signaling is also investigated in order to provide a molecular explanation for the success of NGF-Abs in clinical studies of both pain states. Therefore the market is anticipated to grow in the forecasted period.

In 2021, according to WHO, dementia is a condition in which cognitive performance deteriorates beyond what would be expected as a result of normal biological aging. Dementia is not a natural component of the aging process, even though it mostly affects the elderly. More than 55 million people across the globe suffer from dementia, with roughly 10 million new cases diagnosed each year. Dementia is caused by a variety of diseases and conditions that directly or indirectly harm the brain.  Alzheimer’s disease is the most common type of dementia, accounting for 60 to 70% of all cases. Dementia is the world’s sixth-leading cause of death and one of the leading causes of impairment and dependency among the elderly. Since mouse nerve growth factor for injection is used to treat dementia.

Some major players in the market include Livzon Pharmaceutical Group Inc., Shandong Sinobioway Biomedicine Co Ltd, Wuhan Hiteck Biological Pharma Co Ltd, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Corning 2.5S Nerve Growth Factor (NGF), mouse natural, 1mg is used in vitro to maintain and differentiate sympathetic and sensory neurons as well as neuronal cells. 2/pack, 500g/container.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Livzon Pharmaceutical Group Inc., Shandong Sinobioway Biomedicine Co Ltd, Wuhan Hiteck Biological Pharma Co Ltd, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Mouse Nerve Growth Factor for Injection Market Report by Segment

By Type

• 30μg (15000U)
• 20μg (9000U)

By Distribution Channel

• Peripheral Neuropathies
• Central Neurodegenerative Diseases
• Autoimmune diseases
• Others

Global Mouse Nerve Growth Factor for Injection Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa